Key facts
- Notable investors include Wuxi Guolian Development (Group).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Ruixi Bio-Pharmaceutical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruixi Bio-Pharmaceutical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruixi Bio-Pharmaceutical
Developer of biotechnology-based pharmaceutical research and development programs designed to advance new drug discovery and therapeutic innovation. The company offers drug research capabilities, laboratory development infrastructure, and early-stage biopharmaceutical R&D expertise, enabling healthcare and pharmaceutical sectors to accelerate innovation in novel treatment development and improve medical outcomes.
- Sector
- Healthcare
- HQ
- Wuxi, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Ruixi Bio-Pharmaceutical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruixi Bio-Pharmaceutical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruixi Bio-Pharmaceutical in its N-PORT filings yet. We sweep new filings monthly.